Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001415889-22-006964
Filing Date
2022-06-27
Accepted
2022-06-27 17:15:02
Documents
1
Period of Report
2022-06-17

Document Format Files

Seq Description Document Type Size
1 form4a-06272022_020650.html 4/A  
1 form4a-06272022_020650.xml 4/A 4674
  Complete submission text file 0001415889-22-006964.txt   5997
Mailing Address 333 LAKESIDE DRIVE FOSTER CITY CA 94404
Business Address
Horning Sandra (Reporting) CIK: 0001638709 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-39712 | Film No.: 221045572

Mailing Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107
Business Address 512 2ND STREET, 4TH FLOOR SAN FRANCISCO CA 94107 (415) 651-3316
Olema Pharmaceuticals, Inc. (Issuer) CIK: 0001750284 (see all company filings)

EIN.: 300409740 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations